# Trilogy AB Acetabular Hip System Post Approval Study

> **NCT00715026** · PHASE4 · TERMINATED · sponsor: **Zimmer Biomet** · enrollment: 31 (actual)

## Conditions studied

- Osteoarthritis
- Avascular Necrosis
- Congenital Hip Dysplasia
- Traumatic Arthritis

## Interventions

- **DEVICE:** Trilogy AB Acetabular Hip Implant System

## Key facts

- **NCT ID:** NCT00715026
- **Lead sponsor:** Zimmer Biomet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Sponsor business decision unrelated to clinical performance.
- **Last updated:** 2014-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00715026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00715026, "Trilogy AB Acetabular Hip System Post Approval Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00715026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*